CDMO Avid Bioservices
- 9.540
- -0.050-0.52%
Avid Bioservices News
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum Reaffirms Their Buy Rating on Avid Bioservices (CDMO)
Avid Bioservices (NASDAQ:CDMO) Is Making Moderate Use Of Debt
KeyBanc Maintains Avid Bioservices(CDMO.US) With Buy Rating, Maintains Target Price $14
Why Avid Bioservices Stock Is Moving Higher Wednesday
Avid Bioservices Shares Rise on Upbeat FY25 Outlook
Avid Bioservices Analyst Ratings
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating, Announces Target Price $16
RBC Capital Maintains Avid Bioservices(CDMO.US) With Buy Rating, Maintains Target Price $8
RBC Capital Sticks to Its Buy Rating for Avid Bioservices (CDMO)
Avid Bioservices Reports Mixed Q4 Results; Initiates FY24 Outlook
Earnings Call Summary | Avid Bioservices(CDMO.US) Q4 2024 Earnings Conference
Express News | Avid Bioservices Inc Shares up 10.3% at $7.39 After the Bell Following Results, Outlook
Avid Bioservices | 10-K: Annual report
Express News | Avid Bioservices Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Sales Results
Express News | Avid Bioservices Sees FY25 Revenue $160M-$168M Vs $164M Est
Express News | Avid Bioservices Inc: FY 2025 Revenue Guidance of Between $160 Mln and $168 Mln
Express News | Avid Bioservices Outlook FY Revenue USD 160-168 Million
Express News | Avid Bioservices Q4 Orders USD 30 Million
Express News | Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024
Analysis
Price Target
No Data
